ja_mageia

Allan E. Rubenstein, M.D.
Director of Medical Affairs, Emeritus
New York, New York

Allan E. Rubenstein, M.D., one of the Foundation's co-founders, assumed emeritus status on May 1, 2003 after having served the Foundation as its director of medical affairs for 25 years. During that period he provided invaluable guidance and leadership in the development of the organization, with dramatic impact on it's medical and research programs. His efforts have been a key element in the broader understanding of neurofibromatosis in the medical community. His insights have been, and continue to be, a significant catalyst in the remarkable achievements and successes that have characterized NF research sponsored by the Foundation and elsewhere.

Dr. Rubenstein founded the Mount Sinai Neurofibromatosis Research and Treatment Center. That center was the first interdisciplinary clinic devoted to neurofibromatosis in the world, and has been a model for over 50 other NF clinics in the U.S. and Europe.

Dr. Rubenstein attended Cornell University as an Undergraduate. His medical education started at the University of Rochester School of Medicine, and was completed at Tufts University School of Medicine in Boston. His Neurology specialty training was done at Columbia Presbyterian Medical Center - Neurological Institute in New York. He is certified by, and was an examiner for many years, for the American Board of Psychiatry and Neurology.

Since completing his education he has distinguished himself broadly. He has been recognized in Who's Who in the East and Who's Who in Science and Technology. He has provided counsel to numerous research and governmental agencies, including the NINDS, the Neurogenetics Study Section of the National Cancer Institute, and the Department of Defense NF Research Program. He is a reviewer for several scientific publications and was a Contributing Editor of the Mount Sinai Journal of Medicine for many years.

Dr. Rubenstein is presently Clinical Professor of Neurology and Pediatrics at NYU Langone Medical Center and CEO of NexGenix Pharmaceuticals, a biotechnology company focused on drug development for neurofibromatosis and related sporadic tumors.  He is also the Vice-Chairman and Lead Director of the Cooper Companies (COO, NYSE), a medical products company.

Dr. Rubenstein is married, the father of three and lives in New York City and Nova Scotia.